Researchers develop targeted polymersomes to enhance methotrexate delivery, offering a promising new approach for treating aggressive choriocarcinoma.

Study: ENT-1-Targeted Polymersomes to Enhance the Efficacy of Methotrexate in Choriocarcinoma Treatment. Image Credit: Shutterstock AI Generator / Shutterstock.com.

In a recent study published in Small Science, researchers develop targeted polymersomes loaded with methotrexate for the treatment of gestational choriocarcinoma, a rare and aggressive malignancy originating from the placenta.